iBio, Inc.
IBIO
$1.26
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | -- | 100.00K | 200.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | -- | 100.00K | 200.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | -- | -- | 100.00K | 200.00K |
| SG&A Expenses | -2.18M | 5.11M | 5.17M | 2.50M | 2.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.38M | 8.37M | 9.45M | 6.05M | 5.40M |
| Operating Income | -6.38M | -8.37M | -9.45M | -5.95M | -5.20M |
| Income Before Tax | -10.60M | -7.73M | -8.99M | -5.72M | -5.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.60M | -7.73M | -8.99M | -5.72M | -5.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.60M | -7.73M | -8.99M | -5.72M | -5.16M |
| EBIT | -6.38M | -8.37M | -9.45M | -5.95M | -5.20M |
| EBITDA | -6.23M | -8.21M | -9.30M | -5.76M | -5.00M |
| EPS Basic | -0.07 | -0.06 | -0.09 | -0.29 | -0.36 |
| Normalized Basic EPS | -0.02 | -0.04 | -0.06 | -0.18 | -0.22 |
| EPS Diluted | -0.07 | -0.06 | -0.09 | -0.29 | -0.36 |
| Normalized Diluted EPS | -0.02 | -0.04 | -0.06 | -0.18 | -0.22 |
| Average Basic Shares Outstanding | 145.36M | 119.60M | 99.13M | 19.67M | 14.39M |
| Average Diluted Shares Outstanding | 145.36M | 119.60M | 99.13M | 19.67M | 14.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |